Many women wonder about this, and it's a smart question to ask.
​

With vaginal progesterone, your uterine lining is protected by how much progesterone reaches the uterus itself, not by how much is in your blood. Because it's placed right next to the uterus, it travels there directly. Researchers call this the "uterine first-pass effect."

The lining gets high levels of progesterone even when blood levels look modest. For vaginal progesterone, blood levels don't tell you what's happening in the lining, so we don't use them to check protection.

Vaginal progesterone is the standard way to fully prepare the uterine lining for embryo transfer in IVF (in vitro fertilization), including in women who make no progesterone of their own. That shows it reliably reaches the lining and changes it.

No hormone therapy guarantees zero risk to the lining, and that includes FDA-approved products. Even approved combinations are allowed a small rate of lining thickening (hyperplasia) in their studies. Women who don't take any hormones after menopause also have some baseline risk.

The purpose of progesterone is to bring that risk back down to where it would be without estrogen. Hyperplasia isn't cancer, and when it's caught, it's very treatable.

If the lining weren't well protected, the most common early sign would be unexpected bleeding or spotting. Some light spotting can be normal in the first few months.

Please tell us if you have bleeding that's heavy, lasts a long time, or starts after things have settled.
​

If you aren't having unusual bleeding, routine lining checks aren't recommended for women on any form of HRT, not just Oestra®.
​
​This article is for general education and isn’t a substitute for personalized medical advice. Every body is different, so if you have questions about your own care, our team is here to help through chat.